MTOR and hepatocellular carcinoma: Mounting evidence has indicated there is coordinated activation of protein kinase B (AKT)/ the mammalian target of rapamycin (mTOR) and Ras guanosine triphosphate (GTP)ase (RAS)/mitogen-activated protein kinase (MAPK) pathways in a large subset of human HCC.8